Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Predicting modulaters of TE-driven chromatin 3D structure

ABSTRACT: Predicting modulaters of TE-driven chromatin 3D structure

PROVIDER: PRJNA1046126 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Predicting modulaters of TE-driven chromatin 3D structure (HiC)

Project description:Predicting modulaters of TE-driven chromatin 3D structure (HiC)

| PRJNA1046125 | ENA

Predicting modulaters of TE-driven chromatin 3D structure (RNA-seq)

Project description:Predicting modulaters of TE-driven chromatin 3D structure (RNA-seq)

| PRJNA1046124 | ENA

Predicting modulaters of TE-driven chromatin 3D structure (HiC)

Project description:DNA is tightly packaged in the human nucleus and is wrapped in complex three-dimensional (3D) structures that have been implicated in regulatory processes However, no comprehensive model describes the formation of the 3D genome. At least 40% of the human genome consists of fossilized inactive transposable element (TE) sequences. A role for TEs in 3D genome structure has been suggested by several studies that illustrate how TEs are involved in 3D genome formation. However mechanisms that mediate the formation of TE-mediated 3D contacts is lacking. As TEs are rich in TF binding sites it seems likely that TFs bound to TEs are responsible for forming the 3D genome structure. We used the comprehensive TF binding data available in human and mouse pluripotent stem cells (PSCs), coupled with HiC data to explore the role of TFs bound to TEs in 3D genome organization. Based on these computational predictions we divide TFs into three main classes, those that utilize TEs to drive 3D genome formation, those that are neutral, and a third class that breaks 3D contacts at specific TEs. We then experimentally validate four proteins, and show that SMARCA5 and MAFK are involved in promoting chromatin contacts at TEs, whilst E2F6 and KDM1A are disruptive.

2024-10-26 | GSE248860 | GEO

Predicting modulaters of TE-driven chromatin 3D structure (RNA-seq)

2024-10-26 | GSE248861 | GEO

Predicting modulaters of TE-driven chromatin 3D structure

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-10-26 | GSE248863 | GEO

3D chromatin structure in colon cancer

Project description:We report the application of in situ Hi-C technology to 40 colorectal cancer patients and 10 paired-normal tissue to identify CRC specific changes in 3D chromatin structure. The chromatin contact matrices were generated by the sequencing data and image processing/deep learning-based algorithm was proposed to identify long-range abnormal chromatin interaction patterns in the contact matrices. The tumor specific 3D chromatin structure changes and the enhancer-promoter rewiring mediated by the identified chromatin structure changes were analyzed. The complex chromosome-wide rearrangements such as chromothripsis and its effect to 3D chromatin structure were also observed.

2023-07-27 | GSE137188 | GEO

3D chromatin structure in colon cancer

Project description:3D chromatin structure in colon cancer

| PRJNA564773 | ENA

Predicting the structure and function of coalesced microbial communities

Project description:Predicting the structure and function of coalesced microbial communities

| PRJEB21187 | ENA

DeepC: predicting 3D genome folding using megabase-scale transfer learning

Project description:DeepC: predicting 3D genome folding using megabase-scale transfer learning

| PRJNA565430 | ENA

3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases

Project description:The therapeutic regimens of adjuvant and neoadjuvant chemotherapy for colorectal cancer (CRC) remain largely relied on clinical experience, and thus preclinical models are needed to guide individualized medicine. The investigators are going to establish 3D bioprinted CRC models and organoids from surgically resected tumor tissues of CRC patients with or without liver metastases. In vitro 3D models and organoids will be treated with the same chemotherapy drugs with the corresponding patients from whom the models are derived. The sensitivity of chemotherapy drugs will be tested in these two types of in vitro models, and the actual response to chemotherapy in patients will be evaluated. The predictive ability of 3D models for chemotherapy sensitivity in CRC patients will be compared with that of the organoids. This observational study will validate the potential value of 3D bioprinted tumor models in predicting the response to chemotherapy in CRC.

| 2367475 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data